Myriad Genetics Inc. (MYGN) Stock News, Earnings & History

(NASDAQ:MYGN) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 34.70
52wk low: 22.02
EPS: 1.57
P/E: 21.05
Div Rate: N/A
Yield: N/A
Market Cap: 2.63B
Avg Vol (3m): 1.17M

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENDERSON JOHN T Director Dec 10 Option Exercise 6.70 40,000 267,900 22,746 Dec 11 05:13 PM
HENDERSON JOHN T Director Dec 10 Sale 27.65 40,000 1,106,193 4,000 Dec 11 05:13 PM
LANCHBURY JERRY S Chief Scientific Officer Dec 03 Option Exercise 8.63 20,000 172,600 37,735 Dec 04 04:39 PM
LANCHBURY JERRY S Chief Scientific Officer Dec 03 Sale 27.18 20,000 543,680 17,735 Dec 04 04:39 PM
LANGER DENNIS Director Nov 30 Option Exercise 19.93 45,000 896,700 30,000 Dec 03 04:57 PM
Harrison Robert Gardner Chief Information Officer Nov 30 Sale 29.95 3,480 104,223 2,307 Dec 04 04:38 PM
LANGER DENNIS Director Nov 30 Sale 29.91 45,000 1,345,970 0 Dec 03 04:57 PM
LANGER DENNIS Director Nov 29 Option Exercise 14.12 25,000 352,900 15,000 Dec 03 04:57 PM
LANGER DENNIS Director Nov 29 Sale 29.82 25,000 745,501 0 Dec 03 04:57 PM
Capone Mark Christopher President, MGL Nov 21 Option Exercise 16.53 314 5,190 48,582 Nov 21 12:44 PM
Yahoo, HV, Market Watch, The Wall St. Journal